IHS Chemical Week

Regions :: India/Pakistan

API business of Dr. Reddy’s reports rise in sales

8:16 AM MDT | July 31, 2013 | Deepti Ramesh

The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 6.1% rise in sales in the company’s fiscal first quarter, ended 30 June, compared with the year-ago quarter, to 5.86 billion Indian rupees ($96 million). Earnings figures for the PSAI business have not been disclosed. Growth in the business was muted because of fewer launch molecules to customers during the quarter, Dr. Reddy’s says. During the quarter, five drug master files (DMF) were filed globally...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa